Dr Aaron a présenté à juste titre les effets bénéfiques de l'utilisation des β-agonistes sur la
fonction pulmonaire des patients atteints de bronchopneumopathies chroniques …

Dr Aaron a présenté à juste titre les effets bénéfiques de l'utilisation des β-agonistes sur la
fonction pulmonaire des patients atteints de bronchopneumopathies chroniques …

On se préoccupe de l'innocuité des β-agonistes pour les bronchopneumopathies
chroniques obstructives (BPCO). Les β-agonistes peuvent soulager les symptômes et …

On se préoccupe de l'innocuité des β-agonistes pour les bronchopneumopathies
chroniques obstructives (BPCO). Les β-agonistes peuvent soulager les symptômes et …

Dr Aaron has accurately outlined the beneficial effects of β-agonist use on lung function in
patients with chronic obstructive pulmonary disease (COPD). It is important to point out that …

As Dr D'Urzo pointed out, my recent analysis of β-agonist use in COPD3 did not include the
TORCH study, 4 but this is because it had not been published at that time. As I discussed in …

Much controversy surrounds the use of β-agonists in obstructive lung disease. Regular β 2-
agonist use in asthma results in tolerance to its effects and an increase in asthma-related …

I appreciate the comments of Dr Anthony D'Urzo concerning the recent debate on the safety
of beta-agonist use in chronic obstructive lung disease (COPD).(1) I will respond to his …

A meta-analysis pooled results from 33 randomized placebo-controlled trials of patients with
obstructive lung disease and found that a single dose of β-agonist increased heart rate by 9 …

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated
with high morbidity, mortality and cost to the community. Patients often report symptomatic …